Ethyreal lands $101M to treat both Graves' and thyroid eye disease

Niranjan Kameswaran, Ethyreal Bio CEO June 10, 2026 07:05 AM EDT FinancingStartups Ethyre­al lands $101M to treat both Graves' and thy­roid eye dis­ease Kyle LaHucik Biotech Correspondent A biotech backed by At­las Ven­ture and Medicxi un­cloaked on Wednes­day morn­ing to tack­le the re­lat­ed au­toim­mune con­di­tions Graves’ dis­ease and thy­roid eye dis­ease, and … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER